Brochure
12 Oct 2021

Nanoform launches next-generation STARMAP ®️ v2.0, the AI-based drug candidate selection tool for CESS ®️

PDF 53 kB

The technology utilizes sparse-data AI to augment experimental results from its CESS®️ nanoparticle engineering process with detailed expert knowledge, allowing reliable predictions to be made regarding partners’ potential success of nanoforming their drug molecules.

Content provided by our supplier

Nanoform Finland Oy

  • FI
  • 2019
    On CPhI since
  • 1
    Certificates
  • 100 - 249
    Employees

Other Content from Nanoform Finland Oy